Evidence reviews – April 2019
In April 2019, we reviewed the evidence for urinary incontinence and pelvic organ prolapse in the following areas:
- Urodynamic assessment prior to primary surgery for stress urinary incontinence
- Treatment options for women using absorbent containment products
- Risks to cognitive function for women taking anticholinergic drugs for overactive bladder
- Management of overactive bladder
- Surgical and physical management of stress urinary incontinence
- Effectiveness of multidisciplinary teams for the assessment and management of urinary incontinence or pelvic organ prolapse
- Assessing pelvic organ prolapse
- Lifestyle and conservative management options for pelvic organ prolapse
- Surgical management of pelvic organ prolapse
- Surgical management of pelvic organ prolapse and stress urinary incontinence
- Assessing mesh complications after pelvic floor mesh surgery
- Management of mesh complications
Supplements
- National Guideline Alliance (NGA) technical team list
- Glossary and abbreviations
- Methods
- Economic study selection
See the guideline scope for more information about why we decided to update this guideline.
This page was last updated: